Evaluation of the reproductive toxicity of antiretroviral drug loaded lactoferrin nanoparticles

References

• Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, et al.; Team, H.I.V.P.T.N.S. 2011. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 25:957–966.
   PubMed Web of Science ®Google Scholar
• Actor JK, Hwang S-A, Kruzel ML. 2009. Lactoferrin as a natural immune modulator. Curr Pharm Des. 15:1956–1973.
   PubMed Web of Science ®Google Scholar
• Ahmed F, Ali MJ, Kondapi AK. 2014. Carboplatin loaded protein nanoparticles exhibit improve anti-proliferative activity in retinoblastoma cells. Int J Biol Macromol. 70:572–582.
   PubMed Web of Science ®Google Scholar
• Bessa PC, Machado R, Nürnberger S, Dopler D, Banerjee A, Cunha AM, Rodríguez-Cabello JC, Redl H, Van Griensven M, Reis RL, et al. 2010. Thermoresponsive self-assembled elastin-based nanoparticles for delivery of BMPs. J Control Release. 142:312–318.
   PubMed Web of Science ®Google Scholar
• Bilensoy E, Rouf MA, Vural I, Sen M, Hincal AA. 2006. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: beta-cyclodextrincomplex. AAPS PharmSciTech. 7:E38.
   PubMed Web of Science ®Google Scholar
• Bollimpelli VS, Kumar P, Kumari S, Kondapi AK. 2016. Neuroprotective effect of curcumin-loaded lactoferrin nano particles against rotenone induced neurotoxicity. Neurochem Int. 95:37–45.
   PubMed Web of Science ®Google Scholar
• Chen H, Qin Y, Zhang Q, Jiang W, Tang L, Liu J, He Q. 2011. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas. Eur J Pharm Sci. 44:164–173.
   PubMed Web of Science ®Google Scholar
• Coester CJ, Langer K, Van Briesen H, Kreuter J. 2000. Gelatin nanoparticles by two step desolvation–a new preparation method, surface modifications and cell uptake. J Microencapsul. 17:187–193.
   PubMed Web of Science ®Google Scholar
• D’Cruz OJ, Uckun FM. 2004. Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des. 10:315–336.
   PubMed Web of Science ®Google Scholar
• Darroch JE, Frost JJ. 1999. Women’s interest in vaginal microbicides. Fam Plann Perspect. 31:16–23.
   PubMedGoogle Scholar
• Das Neves J, Sarmento B. 2017. Antiretroviral drug-loaded nanoparticles-in-films: a new option for developing vaginal microbicides? Expert Opin Drug Deliv. 14:449–452.
   PubMed Web of Science ®Google Scholar
• El-Kamel A, Sokar M, Naggar V, Al Gamal S. 2002. Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS PharmSci. 4:E44.
   PubMedGoogle Scholar
• Florisa R, Recio I, Berkhout B, Visser S. 2003. Antibacterial and antiviral effects of milk proteins and derivatives thereof. Curr Pharm Des. 9:1257–1275.
   PubMed Web of Science ®Google Scholar
• Gad S, Chengelis CP. 1998. Acute toxiclogy testing: Perspective and horizons. 2nd Ed. San Diego (CA): Academic Press; p. 404–466.
   Google Scholar
• Gandapu U, Chaitanya RK, Kishore G, Reddy RC, Kondapi AK, Antopolsky M. 2011. Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro. PLoS One. 6:e23388.
   PubMed Web of Science ®Google Scholar
• Golla K, Bhaskar C, Ahmed F, Kondapi AK. 2013a. A target-specific oral formulation of doxorubicin-protein nanoparticles: efficacy and safety in hepatocellular cancer. J Cancer. 4:644–652.
   PubMed Web of Science ®Google Scholar
• Golla K, Cherukuvada B, Ahmed F, Kondapi AK, Sarkar D. 2012. Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats. PLoS One. 7:e51960.
   PubMed Web of Science ®Google Scholar
• Golla K, Reddy PS, Bhaskar C, Kondapi AK. 2013b. Biocompatibility, absorption and safety of protein nanoparticle-based delivery of doxorubicin through oral administration in rats. Drug Deliv. 20:156–167.
   PubMed Web of Science ®Google Scholar
• Gräfe KA, Hoffmann H. 2000. Development and validation of an indirect enzyme-linked immunosorbent assay (ELISA) for the nonsteroidal anti-inflammatory drug S-ibuprofen. Pharmazie. 55:286–292.
   PubMed Web of Science ®Google Scholar
• Gu J, Yang S, Ho EA. 2015. Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells. Mol Pharm. 12:2889–2903.
   PubMed Web of Science ®Google Scholar
• Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. 2008. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 65:1631–1652.
   PubMed Web of Science ®Google Scholar
• Hill K, Thomas K, Abouzahr C, Walker N, Say L, Inoue M, Suzuki E; Maternal Mortality Working Group. 2007. Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data. Lancet 370:1311–1319.
   PubMed Web of Science ®Google Scholar
• Hu K, Shi Y, Jiang W, Han J, Huang S, Jiang X. 2011. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson’s disease. Int J Pharm. 415:273–283.
   PubMed Web of Science ®Google Scholar
• Kizima L, Rodríguez A, Kenney J, Derby N, Mizenina O, Menon R, Seidor S, Zhang S, Levendosky K, Jean-Pierre N, et al. 2014. A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV. PLoS One. 9:e94547.
   PubMed Web of Science ®Google Scholar
• Krishna ADS, Mandraju RK, Kishore G, Kondapi AK, Antopolsky M. 2009. An efficient targeted drug delivery through apotransferrin loaded nanoparticles. PLoS One. 4:e7240.
   PubMed Web of Science ®Google Scholar
• Kumar P, Lakshmi YS, Bhaskar C, Golla K, Kondapi AK, Dezzutti CS. 2015. Improved safety, bioavailability and pharmacokinetics of zidovudine through lactoferrin nanoparticles during oral administration in rats. PLoS One. 10:e0140399.
   PubMed Web of Science ®Google Scholar
• Kumar P, Lakshmi YS, Kondapi AK. 2017a. An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile. HIV Med. 18:452–462.
   PubMed Web of Science ®Google Scholar
• Kumar P, Lakshmi YS, Kondapi AK. 2017b. Triple drug combination of zidovudine, efavirenz and lamivudine loaded lactoferrin nanoparticles: an effective nano first-line regimen for HIV therapy. Pharm Res. 34:257–268.
   PubMed Web of Science ®Google Scholar
• Kumari S, Ahsan SM, Kumar JM, Kondapi AK, Rao NM. 2017. Overcoming blood brain barrier with a dual purpose temozolomide loaded lactoferrin nanoparticles for combating glioma (SERP-17-12433). Sci Rep. 7:6602.
   PubMed Web of Science ®Google Scholar
• Kumari S, Kondapi AK. 2017. Lactoferrin nanoparticle mediated targeted delivery of 5-fluorouracil for enhanced therapeutic efficacy. Int J Biol Macromol. 95:232–237.
   PubMed Web of Science ®Google Scholar
• Kumari S, Kondapi AK. 2018. Receptor-mediated targeted delivery of DNA using lactoferrin nanoparticles. Int J Biol Macromol. 108:401–407.
   PubMed Web of Science ®Google Scholar
• Lakshmi YS, Kumar P, Kishore G, Bhaskar C, Kondapi AK. 2016. Triple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticles. Sci Rep. 6:25479.
   PubMed Web of Science ®Google Scholar
• Legrand D, Elass E, Carpentier M, Mazurier J. 2005. Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci. 62:2549–2559.
   PubMed Web of Science ®Google Scholar
• León-Sicairos N, Reyes-López M, Ordaz-Pichardo C, De La Garza M. 2006. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in entamoeba histolytica. Biochem Cell Biol. 84:327–336.
   PubMed Web of Science ®Google Scholar
• Lim LY, Koh PY, Somani S, Al Robaian M, Karim R, Yean YL, Mitchell J, Tate RJ, Edrada-Ebel R, Blatchford DR, et al. 2015. Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes. Nanomedicine. 11:1445–1454.
   PubMed Web of Science ®Google Scholar
• Liu S, Lu H, Neurath AR, Jiang S. 2005. Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection. Antimicrob Agents Chemother. 49:1830–1836.
   PubMed Web of Science ®Google Scholar
• Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. 2014. Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int. 2014:180549.
   PubMed Web of Science ®Google Scholar
• Lönnerdal B. 2009. Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care. 12:293–297.
   PubMed Web of Science ®Google Scholar
• Machado A, Cunha-Reis C, Araújo F, Nunes R, Seabra V, Ferreira D, Das Neves J, Sarmento B. 2016. Development and in vivo safety assessment of tenofovir-loaded nanoparticles-in-film as a novel vaginal microbicide delivery system. Acta Biomater. 44:332–340.
   PubMed Web of Science ®Google Scholar
• Mallipeddi R, Rohan LC. 2010. Progress in antiretroviral drug delivery using nanotechnology. Int J Nanomedicine. 5:533–547.
   PubMed Web of Science ®Google Scholar
• Mamo T, Moseman EA, Kolishetti N, Salvador-Morales C, Shi J, Kuritzkes DR, Langer R, Von Andrian U, Farokhzad OC. 2010. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine (Lond). 5:269–285.
   PubMed Web of Science ®Google Scholar
• Mudshinge SR, Deore AB, Patil S, Bhalgat CM. 2011. Nanoparticles: emerging carriers for drug delivery. Saudi Pharm J. 19:129–141.
   PubMed Web of Science ®Google Scholar
• Nutan. 2011. Microbicides: a new hope for HIV prevention. Indian J Med Res. 134:939–949.
   PubMed Web of Science ®Google Scholar
• Onishi H, Koyama K, Sakata O, Machida Y. 2010. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats. Drug Dev Ind Pharm. 36:879–884.
   PubMed Web of Science ®Google Scholar
• Park K. 2012. Albumin: a versatile carrier for drug delivery. J Control Release. 157:3.
   PubMed Web of Science ®Google Scholar
• Roseanu A, Florian PE, Moisei M, Sima LE, Evans RW, Trif M. 2010. Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells. Biometals. 23:485–492.
   PubMed Web of Science ®Google Scholar
• Singh S, Sedgh G, Hussain R. 2010. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plann. 41:241–250.
   PubMed Web of Science ®Google Scholar
• Srinivasan P, Zhang J, Martin A, Kelley K, Mcnicholl JM, Buckheit RW Jr., Smith JM, Ham AS. 2016. Safety and pharmacokinetics of quick-dissolving polymeric vaginal films delivering the antiretroviral IQP-0528 for preexposure prophylaxis. Antimicrob Agents Chemother. 60:4140–4150.
   PubMed Web of Science ®Google Scholar
• Su JT, Teller RS, Srinivasan P, Zhang J, Martin A, Sung S, Smith JM, Kiser PF. 2017. A dose ranging pharmacokinetic evaluation of IQP-0528 released from intravaginal rings in non-human primates. Pharm Res. 34:2163–2171.
   PubMed Web of Science ®Google Scholar
• Su Z, Xing L, Chen Y, Xu Y, Yang F, Zhang C, Ping Q, Xiao Y. 2014. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Mol Pharm. 11:1823–1834.
   PubMed Web of Science ®Google Scholar
• Tao W, Richards C, Hamer D. 2008. Enhancement of HIV infection by cellulose sulfate. AIDS Res Hum Retroviruses. 24:925–929.
   PubMed Web of Science ®Google Scholar
• Thurman AR, Clark MR, Doncel GF. 2011. Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies. Infect Dis Obstet Gynecol. 2011:1–10.
   PubMedGoogle Scholar
• Veazey RS. 2008. Microbicide safety/efficacy studies in animals: macaques and small animal models. Curr Opin HIV AIDS. 3:567–573.
   PubMed Web of Science ®Google Scholar
• Wahome N, Pfeiffer T, Ambiel I, Yang Y, Keppler OT, Bosch V, Burkhard P. 2012. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine. Chem Biol Drug Des. 80:349–357.
   PubMed Web of Science ®Google Scholar
• Wang G, Uludag H. 2008. Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opin Drug Deliv. 5:499–515.
   PubMed Web of Science ®Google Scholar
• Ward PP, Uribe-Luna S, Conneely OM. 2002. Lactoferrin and host defense. Biochem Cell Biol. 80:95–102.
   PubMed Web of Science ®Google Scholar
• Weber C, Coester C, Kreuter J, Langer K. 2000. Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm. 194:91–102.
   PubMed Web of Science ®Google Scholar
• Woolfson AD, Malcolm RK, Morrow RJ, Toner CF, Mccullagh SD. 2006. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Int J Pharm. 325:82–89.
   PubMed Web of Science ®Google Scholar
• Zhang Z-H, Wang X-P, Ayman WY, Munyendo WLL, Lv H-X, Zhou J-P. 2013. Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Deliv. 20:86–93.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Meng H, Wang N, Donovan MJ, Fu T, You M, Chen Z, Zhang X, Tan W. 2013. A controlled-release nanocarrier with extracellular pH value driven tumor targeting and translocation for drug delivery. Angew Chem Int Ed Engl. 52:7487–7491.
   PubMed Web of Science ®Google Scholar